BIO International Convention, 2016

6-9 June 2016
San Francisco, CA

ASCO Annual Meeting, 2016

3-7 June 2016
Chicago, IL

Trethera Appoints Dr. Johanna Holldack as President & CEO

Beverly Hills, CA, 1 November 2015 – Trethera, a biotechnology company focused on the discovery and development of innovative small molecules for the treatment of hematological and solid tumors today announced the appointment of Dr. Johanna Holldack as President and Chief Executive Officer. The appointment is effective immediately.

Read full press release